BACK

輝瑞與AZ疫苗對不同新冠變種的效果

This article was published on
June 28, 2021

This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.

輝瑞與AZ疫苗對不同新冠變種的效果說明

輝瑞與AZ疫苗對不同新冠變種的效果說明

Publication

What our experts say

輝瑞/BioNTech BNT162b2

牛津/AZ ChAdOx1 nCoV-19

Context and background

Resources

Resources

  1. Sheikh et. al. (2021) SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness. The Lancet. published online. doi: https://doi.org/10.1016/S0140-6736(21)01358-1
  2. Bernal et. al. (2021) Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 373:n1088 doi: https://doi.org/10.1136/bmj.n1088
  3. Public Health England. Vaccines highly effective against hospitalisation from Delta variant. 2021/6/4 https://www.gov.uk/government/news/vaccines-highly-effective-against-hospitalisation-from-delta-variant
  4. The Covid Delta variant: how effective are the vaccines? The Guardian. 2021/6/15 https://www.theguardian.com/world/2021/jun/15/the-covid-delta-variant-how-effective-are-the-vaccines
  5. Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant. 2021/6/21 https://khub.net/web/phe-national/public-library/-/document_library/v2WsRK3ZlEig/view/479607266

Media briefing

Media Release

Expert Comments: 

No items found.

Q&A

No items found.